This bill creates a new mental health initiative called the School-Based Partnerships for Access and Resilience for Kids program within the Department of Children and Families to support students in New Jersey schools. It requires school districts, charter schools, and renaissance school projects to develop specific mental health support programs that connect students with high behavioral health needs to the new SPARK program navigator. The program will provide same-day psychiatric consultations, referrals to community care, and assistance with returning to school after a mental health crisis, all of which require written parental consent. Additionally, the legislation mandates that schools establish clear guidelines for privacy, care coordination, and transition plans to ensure consistent support across the state.
This bill directs New Jersey's Department of Children and Families to improve access to mental health care for children and their families. It requires the department to expand services through the New Jersey Pediatric Psychiatry Collaborative, which includes adding telehealth options, providing real-time psychiatric support to pediatric doctors, and offering better training and referral systems. The legislation also mandates greater transparency by setting specific performance goals for service providers, making contract results public, and launching a public awareness campaign to help families find care. Additionally, the bill establishes a new requirement for hospitals and clinics to report standardized data on how often children seek psychiatric or behavioral health services.
This bill requires all corn masa flour and wet corn masa products sold in New Jersey to be fortified with folic acid to help reduce the risk of neural tube defects, which disproportionately affect Latino communities. Manufacturers must add specific amounts of folic acid to dry flour and wet products and clearly label these ingredients on nutrition facts panels. The law allows the state health commissioner to grant exemptions for specific products or companies if necessary. By making these changes, the legislation aims to ensure that dietary staples common in Central and South American cuisines provide essential nutritional benefits comparable to other fortified grains.
This New Jersey bill mandates that health insurance plans and Medicaid cover medically necessary tests and FDA-approved treatments designed to slow the progression of Alzheimer's disease and related disorders. The law applies to hospital service, medical service, and health service corporation contracts, as well as individual and group health insurance policies issued or renewed in the state. A key provision ensures that these specific Alzheimer's treatments are not subject to step therapy requirements, meaning patients can access them without needing to try other medications first. Additionally, the coverage must be provided at the same level as benefits for other medical conditions.
This bill permanently extends pay parity for telemedicine and telehealth services in New Jersey, requiring health insurance carriers to reimburse providers at the same rates as in-person care. It directly affects insurance companies, healthcare providers, and patients by mandating that out-of-pocket costs like deductibles and copayments for virtual visits cannot exceed those for in-person appointments. The legislation also prohibits insurers from restricting telehealth platforms, limiting service locations, or denying coverage for routine remote monitoring if the same care would be covered in person. Additionally, carriers must continue to allow patients to choose between in-person and virtual care rather than forcing telehealth as a substitute.
This bill (A 3434) requires New Jersey dialysis centers to allow patients receiving treatment to be accompanied by a designated support person who can assist with communication, mobility, and care decisions. It directly affects dialysis patients and the centers providing their treatment. Centers must create and display clear written policies for support person access, implement reasonable health/safety rules (without unnecessary restrictions), and train staff on these policies. The New Jersey Department of Health will enforce the law, investigate complaints about denied access, and impose penalties for non-compliance. The law takes effect immediately upon passage.
This bill requires health insurance plans in New Jersey to continue covering adult children with disabilities who are 26 or older, provided they cannot work due to a physical or intellectual disability and are financially dependent on their parent. It amends existing law to extend coverage beyond the standard age limit of 26 for this specific group, ensuring they maintain health insurance through their parent's plan. The bill prohibits denial of coverage based on factors like marriage, having a child, or school status, which commonly affected young adults with disabilities. This change directly impacts young adults with disabilities in New Jersey who would otherwise lose coverage at age 26 but meet the eligibility criteria.
This bill prohibits health insurance carriers from denying coverage for nonopioid pain medications in favor of opioids or requiring patients to try opioids first. It requires insurers to treat FDA-approved nonopioid drugs equally to opioids in formularies, meaning coverage restrictions, prior authorization, and cost-sharing tiers must be no more restrictive for nonopioid drugs. The law applies to state health benefit plans, school employee health programs, and Medicaid for acute pain treatment. It takes effect January 1, 2026, directly affecting insurers and patients covered by these plans.
This bill authorizes certified medication aides to administer medications to residents in New Jersey nursing homes, expanding their current scope of practice. It directly affects nursing homes struggling with staffing shortages and certified medication aides who would now be permitted to perform this role in nursing home settings (currently allowed in 38 states and other care facilities like assisted living residences). The key mechanism is amending existing law to explicitly include nursing homes under the certification framework for medication aides, addressing legislative findings that staffing challenges are severe in nursing homes post-pandemic. This change aims to alleviate staffing pressures by allowing medication aides to support resident care needs within existing certification standards.
This New Jersey bill creates a new crime called fertility fraud, which specifically targets licensed health care practitioners who knowingly use a patient's reproductive material without their written consent. Under the law, a practitioner commits this offense if they use their own sperm or eggs or the material of another person to cause a pregnancy without the patient's informed agreement. If convicted of this third-degree crime, the individual faces up to five years in prison, a fine of $15,000, and the mandatory permanent revocation of their medical license. Additionally, the legislation extends the statute of limitations for prosecuting this specific offense to 20 years from the date of the treatment or 10 years from when the victim discovers the fraud, whichever is later.
